Assay Detail
Functional
CHEMBL5141281
Review assay metadata, readout intent, target linkage, and publication context from the same page.
Antiproliferative activity against mouse BaF3 cells harboring JAK3 M5111 mutant assessed as inhibition of cell growth measured after 72 hrs by CCK-8 assay
11
Total Activities
11
Compounds Tested
1
Activity Types
0
Assay Parameters
Assay Information
| Assay Type | Functional |
| Organism | Mus musculus |
| Cell Type | BaF3 |
| Confidence | 1 — Organism |
| Curated By | Autocuration |
Publication
Discovery of Hexahydrofuro[3,2-<i>b</i>]furans as New Kinase-Selective and Orally Bioavailable JAK3 Inhibitors for the Treatment of Leukemia Harboring a JAK3 Activating Mutant.
Activity Statistics
| Type | Count | Avg pChEMBL | Best pChEMBL |
|---|---|---|---|
| IC50 | 11 | 7.12 | 7.70 |
Compounds Tested
| Compound | Name | Phase | Activities | Best pChEMBL |
|---|---|---|---|---|
| CHEMBL5191734 | — | — | 1 | 7.70 |
| CHEMBL5193702 | — | — | 1 | 7.64 |
| CHEMBL5174210 | — | — | 1 | 7.60 |
| CHEMBL4085457 | RITLECITINIB | 4.0 | 1 | 7.55 |
| CHEMBL5180117 | — | — | 1 | 7.33 |
| CHEMBL5192736 | — | — | 1 | 7.25 |
| CHEMBL5201705 | — | — | 1 | 7.05 |
| CHEMBL5176661 | — | — | 1 | 6.96 |
| CHEMBL221959 | TOFACITINIB | 4.0 | 1 | 6.75 |
| CHEMBL5186937 | — | — | 1 | 6.75 |
| CHEMBL5185440 | — | — | 1 | 5.78 |
Activity Data
| Compound | Name | Type | Rel. | Value | Units | pChEMBL |
|---|---|---|---|---|---|---|
| CHEMBL5191734 | — | IC50 | = | 20.1 | nM | 7.70 |
| CHEMBL5193702 | — | IC50 | = | 22.9 | nM | 7.64 |
| CHEMBL5174210 | — | IC50 | = | 24.9 | nM | 7.60 |
| CHEMBL4085457 | RITLECITINIB | IC50 | = | 28.1 | nM | 7.55 |
| CHEMBL5180117 | — | IC50 | = | 46.4 | nM | 7.33 |
| CHEMBL5192736 | — | IC50 | = | 56.4 | nM | 7.25 |
| CHEMBL5201705 | — | IC50 | = | 88.6 | nM | 7.05 |
| CHEMBL5176661 | — | IC50 | = | 108.4 | nM | 6.96 |
| CHEMBL221959 | TOFACITINIB | IC50 | = | 177.3 | nM | 6.75 |
| CHEMBL5186937 | — | IC50 | = | 179.3 | nM | 6.75 |
| CHEMBL5185440 | — | IC50 | = | 1648.3 | nM | 5.78 |